Seegene Launches New Test for Multidrug-Resistant Organisms in Europe
The assay is CE marked under the European Union In Vitro Diagnostic Regulation and identifies resistance genes to help prevent hospital-acquired infections.
Read MorePosted by CLP Edit Staff | Jun 12, 2026 | Rapid Assays |
The assay is CE marked under the European Union In Vitro Diagnostic Regulation and identifies resistance genes to help prevent hospital-acquired infections.
Read MorePosted by CLP Edit Staff | Jun 11, 2026 | Compliance |
The funding, allocated to the Centers for Disease Control and Prevention, aims to establish more accurate normal ranges for children’s medical results.
Read MorePosted by CLP Edit Staff | Jun 5, 2026 | Microbiology |
The new capability helps clinicians determine if a patient’s infection will respond to gepotidacin before prescribing the treatment.
Read MorePosted by CLP Edit Staff | Jun 5, 2026 | Microbiology, Molecular Diagnostics |
The panel detects fungal DNA in plasma to help identify specific pathogens in immunocompromised patients.
Read MorePosted by CLP Edit Staff | Jun 2, 2026 | Sexually Transmitted Diseases |
The facility will support the clinical validation of diagnostic kits that provide results via a mobile app without the need for laboratory processing.
Read More